205 related articles for article (PubMed ID: 32436862)
41. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
42. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/β-catenin signaling pathway.
Yang X; Tang S; Dai C; Li D; Zhang S; Deng S; Zhou Y; Xiao X
Food Chem Toxicol; 2017 Jul; 105():161-176. PubMed ID: 28343033
[TBL] [Abstract][Full Text] [Related]
43. miRNA-874-3p inhibits the migration, invasion and proliferation of breast cancer cells by targeting VDAC1.
Yang H; Wang Z; Hu S; Chen L; Li W; Yang Z
Aging (Albany NY); 2023 Jan; 15(3):705-717. PubMed ID: 36750173
[TBL] [Abstract][Full Text] [Related]
44. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
Zeng YT; Liu XF; Yang WT; Zheng PS
Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
[TBL] [Abstract][Full Text] [Related]
45. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.
Head SA; Shi W; Zhao L; Gorshkov K; Pasunooti K; Chen Y; Deng Z; Li RJ; Shim JS; Tan W; Hartung T; Zhang J; Zhao Y; Colombini M; Liu JO
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7276-85. PubMed ID: 26655341
[TBL] [Abstract][Full Text] [Related]
46. lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma.
Liu H; Zhu C; Xu Z; Wang J; Qian L; Zhou Q; Shen Z; Zhao W; Xiao W; Chen L; Zhou Y
Cancer Sci; 2020 Nov; 111(11):4129-4141. PubMed ID: 32920922
[TBL] [Abstract][Full Text] [Related]
47. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
48. Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
Lv Q; Wu K; Liu F; Wu W; Chen Y; Zhang W
Int J Oncol; 2018 Oct; 53(4):1809-1817. PubMed ID: 30066843
[TBL] [Abstract][Full Text] [Related]
49. MLL/KMT2A translocations in diffuse large B-cell lymphomas.
Gindin T; Murty V; Alobeid B; Bhagat G
Hematol Oncol; 2015 Dec; 33(4):239-46. PubMed ID: 25131304
[TBL] [Abstract][Full Text] [Related]
50. Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer.
Song Y; Guo Q; Gao S; Hua K
Biochem Biophys Res Commun; 2018 Apr; 498(3):686-692. PubMed ID: 29524410
[TBL] [Abstract][Full Text] [Related]
51. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
52. MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer.
Li Q; Zhang Y; Jiang Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):51-58. PubMed ID: 30454902
[TBL] [Abstract][Full Text] [Related]
53. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
[TBL] [Abstract][Full Text] [Related]
54. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
[No Abstract] [Full Text] [Related]
55. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
56. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
57. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
58. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial Calcium Uniporter (MCU) that Modulates Mitochondrial Calcium Uptake and Facilitates Endometrial Cancer Progression through Interaction with VDAC1.
Xiao H; Ma L; Ding J; Wang H; Bi X; Tan F; Piao W
Curr Cancer Drug Targets; 2024; 24(3):354-367. PubMed ID: 37702230
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
Luan X; Wang Y
Oncol Rep; 2017 Jul; 38(1):159-166. PubMed ID: 28534991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]